Chemoinformaics analysis of BICYCLO-(2.1.0)-PENTANE-5-CARBOXYLIC-ACID-1-METHYL-ETHYL-ESTER
Molecular Weight | 154.209 | nRot | 2 |
Heavy Atom Molecular Weight | 140.097 | nRig | 7 |
Exact Molecular Weight | 154.099 | nRing | 2 |
Solubility: LogS | -2.517 | nHRing | 0 |
Solubility: LogP | 2.175 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 25.9691 |
nHD | 0 | BPOL | 16.6489 |
QED | 0.565 |
Synth | 3.155 |
Natural Product Likeliness | 1.156 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.007 |
Pgp-sub | 0 |
HIA | 0.002 |
CACO-2 | -4.456 |
MDCK | 0.000045 |
BBB | 0.991 |
PPB | 0.392864 |
VDSS | 0.986 |
FU | 0.723902 |
CYP1A2-inh | 0.814 |
CYP1A2-sub | 0.851 |
CYP2c19-inh | 0.302 |
CYP2c19-sub | 0.868 |
CYP2c9-inh | 0.033 |
CYP2c9-sub | 0.257 |
CYP2d6-inh | 0.012 |
CYP2d6-sub | 0.567 |
CYP3a4-inh | 0.039 |
CYP3a4-sub | 0.264 |
CL | 10.766 |
T12 | 0.271 |
hERG | 0.012 |
Ames | 0.054 |
ROA | 0.171 |
SkinSen | 0.133 |
Carcinogencity | 0.09 |
EI | 0.82 |
Respiratory | 0.231 |
NR-Aromatase | 0.007 |
Antiviral | No |
Prediction | 0.930064 |